Literature DB >> 20134101

Is pentraxin 3 involved in obesity-induced decrease in arterial distensibility?

Asako Miyaki1, Seiji Maeda, Mutsuko Yoshizawa, Maiko Misono, Hiroyuki Sasai, Nobutake Shimojo, Kiyoji Tanaka, Ryuichi Ajisaka.   

Abstract

AIM: Obesity is a strong risk factor for cardiovascular morbidity and mortality. In addition, decreased central arterial distensibility is recognized as an independent risk factor for cardiovascular disease (CVD). Obese subjects exhibit low arterial distensibillity; however, the mechanism responsible for the decrease in arterial distensibility in obese subjects has not yet been elucidated. Pentraxin 3 (PTX3), a recently identified member of the pentraxin family of proteins, is produced in areas of atherosclerosis. A recent study has revealed that the PTX3 level may indicate the vascular inflammatory status. The aim of this study was to investigate plasma PTX3 concentrations and arterial distensibility in obese subjects.
METHODS: Eleven obese men (age: 44+/-2 years, body mass index [BMI]: 32+/-1 kg/m(2)) and 14 nonobese men (age: 42+/-2 years, BMI: 26+/-1 kg/m(2)) participated in this study. We measured arterial compliance (using simultaneous B-mode ultrasound and arterial applanation tonometry of the common carotid artery); beta-stiffness index, an index of arterial compliance adjusted for distending pressure; and plasma PTX3 concentrations.
RESULTS: Arterial compliance was significantly lower and the beta-stiffness index was significantly higher in obese men than in non-obese men. Plasma PTX3 concentration was markedly higher in obese than non-obese men.
CONCLUSIONS: Obese men have lower arterial distensibility and higher circulating PTX3 levels than non-obese men; therefore, higher PTX3 levels and decreased arterial distensibility coexist in obese men. The high PTX3 concentrations in obese men may be involved in the mechanism underlying the obesity-induced decrease in arterial distensibility.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20134101     DOI: 10.5551/jat.2741

Source DB:  PubMed          Journal:  J Atheroscler Thromb        ISSN: 1340-3478            Impact factor:   4.928


  12 in total

1.  Plasma Pentraxin 3 as a biomarker of metabolic syndrome.

Authors:  Fatih Kardas; Leyla Akın; Selim Kurtoglu; Mustafa Kendirci; Zehra Kardas
Journal:  Indian J Pediatr       Date:  2014-07-29       Impact factor: 1.967

2.  Childhood obesity, metabolic syndrome and Pentraxin-3.

Authors:  P S N Menon
Journal:  Indian J Pediatr       Date:  2014-12-13       Impact factor: 1.967

3.  Does low pentraxin-3 levels associate with polycystic ovary syndrome and obesity?

Authors:  Figen Kir Sahin; Serap Baydur Sahin; Gulsah Balik; Ulku Mete Ural; Yesim Bayoglu Tekin; Medine Cumhur Cure; Senol Senturk; Suleyman Yuce; Erkan Cure
Journal:  Int J Clin Exp Med       Date:  2014-10-15

4.  TREM-1 and pentraxin-3 plasma levels and their association with obstructive sleep apnea, obesity, and endothelial function in children.

Authors:  Jinkwan Kim; David Gozal; Rakesh Bhattacharjee; Leila Kheirandish-Gozal
Journal:  Sleep       Date:  2013-06-01       Impact factor: 5.849

5.  Pentraxin 3 as a Marker for Cardiovascular Disease Risk in Overweight and Obese Children.

Authors:  Pinar Dervisoglu; Bahri Elmas
Journal:  Acta Cardiol Sin       Date:  2021-03       Impact factor: 2.672

6.  Meta-inflammatory state and insulin resistance can improve after 10 weeks of combined all-extremity high-intensity interval training in sedentary overweight/obese females: a quasi-experimental study.

Authors:  Nakisa Soltani; Sayed Mohammad Marandi; Mohammad Kazemi; Nafiseh Esmaeil
Journal:  J Diabetes Metab Disord       Date:  2020-07-18

7.  Elevated circulating levels and tissue expression of pentraxin 3 in uremia: a reflection of endothelial dysfunction.

Authors:  Anna Witasp; Mikael Rydén; Juan Jesús Carrero; Abdul Rashid Qureshi; Louise Nordfors; Erik Näslund; Folke Hammarqvist; Samsul Arefin; Karolina Kublickiene; Peter Stenvinkel
Journal:  PLoS One       Date:  2013-05-03       Impact factor: 3.240

Review 8.  The Potential Role of Aerobic Exercise-Induced Pentraxin 3 on Obesity-Related Inflammation and Metabolic Dysregulation.

Authors:  Aaron L Slusher; Chun-Jung Huang; Edmund O Acevedo
Journal:  Mediators Inflamm       Date:  2017-03-17       Impact factor: 4.711

9.  Host-protective effect of circulating pentraxin 3 (PTX3) and complex formation with neutrophil extracellular traps.

Authors:  Kenji Daigo; Takao Hamakubo
Journal:  Front Immunol       Date:  2012-12-13       Impact factor: 7.561

10.  Correlation between pentraxin-3 and endothelial dysfunction in obstructive sleep apnea syndrome.

Authors:  Asiye Kanbay; Elif Kaya; Hakan Büyükoğlan; Mehmet Güngör Kaya; Zuhal Özer Şimşek; Nuri Tutar; Ramazan Demir
Journal:  Ann Thorac Med       Date:  2015 Jul-Sep       Impact factor: 2.219

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.